Publication | Closed Access
A phase II study of pembrolizumab and paclitaxel in patients with relapsed or refractory small-cell lung cancer
77
Citations
36
References
2019
Year
OncologyPathologyPhase Ii StudyImmune Checkpoint InhibitorCancer TreatmentMedicineRadiation OncologyLung Cancer
| Year | Citations | |
|---|---|---|
Page 1
Page 1